GlassScriptPhysician profile
Amber Campbell
NPI 1194353375
$2,423.61
in general payments reported to CMS, 2019-2025
18 companies · $681 in 2025
The $681 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.05 · 2022: $169 · 2023: $819 · 2024: $734 · 2025: $681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,234.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,158.83 | 2023-2025 | |
| Amgen INC. | $231.72 | 2023-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $188.24 | 2024 | Mounjaro, Zepbound, Trulicity |
| Astrazeneca Pharmaceuticals LP | $174.74 | 2022-2025 | Airsupra, Breztri |
| Pfizer INC. | $148.13 | 2021-2025 | |
| Novo Nordisk INC | $108.47 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Horizon Therapeutics Plc | $84.09 | 2022 | |
| Amarin Pharma, INC. | $46.80 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $39.55 | 2023 | Gardasil 9, Pneumovax 23, Vaxneuvance |
| Medtronic, INC. | $38.19 | 2023 | Minimed 780g, Guardian Connect |
| Sanofi-Aventis U.S. LLC | $36.97 | 2025 | |
| Edwards Lifesciences Corporation | $33.73 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Novartis Pharmaceuticals Corporation | $27.41 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $25.99 | 2024 | Caplyta |
| Exact Sciences Corporation | $23.54 | 2025 | Cologuard Collection Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $20.91 | 2024 | Veozah |
| Hikma Pharmaceuticals USA | $20.39 | 2023 | Ryaltris |
| Acella Pharmaceuticals, LLC | $15.91 | 2023 | NP Thyroid 60 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.